Skip to content

Nasdaq · CIK 0001783183

PHAT Phathom Pharmaceuticals, Inc.

Insider trading from SEC Form 4. Last filing 4 d ago. Close $7.25 on Oct 9, 2026, +8% from the 52-week low and -60% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
14
with a Form 4 at this company

Price and insider trades, last year

PHATOct 9, 2026 · close 7.25

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at Phathom Pharmaceuticals, Inc., scored.

ScoreInsiderValueHoldingsPrice contextFiled
15WeakRobert Charles Breedlove
Principal Accounting Officer
sell
$7,079
524 shares
-1%+500% from low-28% from high
15WeakRobert Charles Breedlove
Principal Accounting Officer
sell
$5,573
461 shares
-1%+439% from low-37% from high
15WeakRobert Charles Breedlove
Principal Accounting Officer
sell
$14k
1,692 shares
-3%+264% from low-57% from high
31WeakJames N Topper
director
buy
$15k
3,780 shares
+7%+70% from low-80% from high
39WeakJames N Topper
director
buy
$24k
7,420 shares
+15%+45% from low-83% from high
50ModerateJames N Topper
director
buy
$153k
48,203 shares
-+37% from low-84% from high
44ModerateAsit Parikh
director
buy
$25k
10,000 shares
+12%0% from low-88% from high
22WeakMolly Henderson
CFO and CBO
sell
$17k
3,678 shares
-4%+15% from low-75% from high
44ModerateTerrie Curran
President and Chief Executive
sell
$126k
19,109 shares
-5%-
36WeakMolly Henderson
CFO and CBO
sell
$43k
6,583 shares
-7%-
30WeakMolly Henderson
CFO and CBO
sell
$10k
1,291 shares
-1%-
28WeakAzmi Nabulsi
Chief Operating Officer
sell
$8,944
1,118 shares
-0%-
39WeakFrank Karbe
director
buy
$99k
12,500 shares
+28%-
35WeakAsit Parikh
director
buy
$81k
10,000 shares
+15%-

Transactions

The last 55 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Oct 6, 2026Sanjeev Narula
Chief Financial & Bus. Officer
FTax withholding
Common Stock
-13,485$6.78$91k214,7184 d ago
Sep 3, 2026Robert Charles Breedlove
Principal Accounting Officer
FTax withholding
Common Stock
-460$9.05$4,16359,46534 d ago
Dec 19, 2025Asit Parikh
director
MOption exercise
Common Stock
+8,750$10.30$90k122,250Dec 23, 2025
Dec 19, 2025Asit Parikh
director
MOption exercise
Common Stock (Right to Buy)derivative
-8,750$0.00$08,750Dec 23, 2025
Dec 18, 2025Robert Charles Breedlove
Principal Accounting Officer
FTax withholding
Common Stock
-230$16.28$3,74447,844Dec 19, 2025
Dec 17, 2025Steven L Basta
President and CEO
AGrant or award
Common Stock
+62,038$0.00$0145,288Dec 19, 2025
Dec 17, 2025Anne Marie Cook
Chief Legal Off. & Corp. Sec.
AGrant or award
Common Stock
+17,370$0.00$017,370Dec 19, 2025
Dec 17, 2025Steven L Basta
President and CEO
FTax withholding
Common Stock
-31,502$15.36$484k113,786Dec 19, 2025
Dec 17, 2025Anne Marie Cook
Chief Legal Off. & Corp. Sec.
FTax withholding
Common Stock
-7,703$15.36$118k9,667Dec 19, 2025
Nov 28, 2025Steven L Basta
President and CEO
MOption exercise
Common Stock
+90,000$0.00$0131,625Dec 2, 2025
Nov 28, 2025Steven L Basta
President and CEO
FTax withholding
Common Stock
-48,375$15.62$756k83,250Dec 2, 2025
Nov 28, 2025Steven L Basta
President and CEO
MOption exercise
Performance Sharesderivative
-90,000$0.00$0180,000Dec 2, 2025
Nov 3, 2025Robert Charles Breedlove
Principal Accounting Officer
SOpen-market sale
Common Stock
-524$13.51$7,07947,407Nov 5, 2025
Oct 6, 2025Sanjeev Narula
Chief Financial & Bus. Officer
AGrant or award
Stock Option (Right to Buy)derivative
+200,000$0.00$0200,000Oct 7, 2025
Sep 25, 2025Steven L Basta
President and CEO
MOption exercise
Common Stock
+90,000$0.00$090,000Sep 26, 2025
Sep 25, 2025Steven L Basta
President and CEO
FTax withholding
Common Stock
-48,375$11.66$564k41,625Sep 26, 2025
Sep 25, 2025Steven L Basta
President and CEO
MOption exercise
Performance Sharesderivative
-90,000$0.00$0270,000Sep 26, 2025
Sep 5, 2025Robert Charles Breedlove
Principal Accounting Officer
SOpen-market sale
Common Stock
-461$12.09$5,57347,931Sep 9, 2025
Jul 16, 2025Robert Charles Breedlove
Principal Accounting Officer
SOpen-market sale
Common Stock
-1,692$8.36$14k48,392Jul 18, 2025
Jun 23, 2025Anne Marie Cook
Chief Legal Off. & Corp. Sec.
AGrant or award
Stock Option (Right to Buy)derivative
+210,000$0.00$0210,000Jun 24, 2025
Jun 3, 2025Michael F Cola
director
AGrant or award
Common Stock
+10,500$0.00$039,798Jun 5, 2025
Jun 3, 2025James N Topper
director, owner
AGrant or award
Common Stock
+10,500$0.00$042,596Jun 5, 2025
Jun 3, 2025Heidi Fields
director
AGrant or award
Common Stock
+10,500$0.00$030,000Jun 5, 2025
Jun 3, 2025Frank Karbe
director
AGrant or award
Common Stock
+10,500$0.00$067,500Jun 5, 2025
Jun 3, 2025Mark Stenhouse
director
AGrant or award
Common Stock
+10,500$0.00$030,000Jun 5, 2025
Jun 3, 2025Asit Parikh
director
AGrant or award
Common Stock
+10,500$0.00$0113,500Jun 5, 2025
Jun 3, 2025Mark Stenhouse
director
AGrant or award
Stock Option (Right to Buy)derivative
+17,500$0.00$017,500Jun 5, 2025
Jun 3, 2025Asit Parikh
director
AGrant or award
Stock Option (Right to Buy)derivative
+17,500$0.00$017,500Jun 5, 2025
Jun 3, 2025Heidi Fields
director
AGrant or award
Stock Option (Right to Buy)derivative
+17,500$0.00$017,500Jun 5, 2025
Jun 3, 2025Michael F Cola
director
AGrant or award
Stock Option (Right to Buy)derivative
+17,500$0.00$017,500Jun 5, 2025
Jun 3, 2025Frank Karbe
director
AGrant or award
Stock Option (Right to Buy)derivative
+17,500$0.00$017,500Jun 5, 2025
Jun 3, 2025James N Topper
director, owner
AGrant or award
Stock Option (Right to Buy)derivative
+17,500$0.00$017,500Jun 5, 2025
May 21, 2025James N Topper
director
POpen-market purchase
Common Stockindirect: By Frazier Life Sciences X, L.P.
+3,780$3.86$15k59,403May 23, 2025
May 19, 2025Robert Charles Breedlove
Principal Accounting Officer
AGrant or award
Stock Option (Right to Buy)derivative
+33,000$0.00$033,000May 21, 2025
May 13, 2025James N Topper
director
POpen-market purchase
Common Stockindirect: By Frazier Life Sciences X, L.P.
+1,120$3.16$3,54349,323May 15, 2025
May 14, 2025James N Topper
director
POpen-market purchase
Common Stockindirect: By Frazier Life Sciences X, L.P.
+6,300$3.32$21k55,623May 15, 2025
May 9, 2025James N Topper
director
POpen-market purchase
Common Stockindirect: By Frazier Life Sciences X, L.P.
+33,376$3.19$107k33,376May 13, 2025
May 9, 2025James N Topper
director
POpen-market purchase
Common Stockindirect: By Frazier Life Sciences X, L.P.
+2,226$3.62$8,05335,602May 13, 2025
May 12, 2025James N Topper
director
POpen-market purchase
Common Stockindirect: By Frazier Life Sciences X, L.P.
+12,601$3.04$38k48,203May 13, 2025
May 6, 2025Asit Parikh
director
POpen-market purchase
Common Stock
+5,000$2.60$13k90,500May 8, 2025
May 7, 2025Asit Parikh
director
POpen-market purchase
Common Stock
+5,000$2.40$12k95,500May 8, 2025
Apr 16, 2025Theodore R Schroeder
director
AGrant or award
Common Stock
+21,000$0.00$021,000Apr 16, 2025
Apr 16, 2025Theodore R Schroeder
director
AGrant or award
Common Stock (Right to Buy)derivative
+35,000$0.00$035,000Apr 16, 2025
Apr 7, 2025Molly Henderson
CFO and CBO
SOpen-market sale
Common Stock
-3,678$4.55$17k89,868Apr 8, 2025
Apr 3, 2025Steven L Basta
President and CEO
AGrant or award
Performance Sharesderivative
+360,000$0.00$0360,000Apr 3, 2025
Apr 3, 2025Steven L Basta
President and CEO
AGrant or award
Stock Option (Right to Buy)derivative
+1,085,000$0.00$01,085,000Apr 3, 2025
Feb 27, 2025Terrie Curran
President and Chief Executive
AGrant or award
Stock Option (Right to Buy)derivative
+342,500$0.00$0342,500Mar 3, 2025
Feb 27, 2025Molly Henderson
CFO and CBO
AGrant or award
Common Stock
+72,000$0.00$0165,546Mar 3, 2025
Feb 27, 2025Molly Henderson
CFO and CBO
AGrant or award
Stock Option (Right to Buy)derivative
+50,000$0.00$050,000Mar 3, 2025
Jan 21, 2025Terrie Curran
President and Chief Executive
SOpen-market sale
Common Stock
-19,109$6.59$126k360,465Jan 23, 2025
Jan 21, 2025Molly Henderson
CFO and CBO
SOpen-market sale
Common Stock
-6,583$6.59$43k93,546Jan 23, 2025
Dec 19, 2024Molly Henderson
CFO and CBO
SOpen-market sale
Common Stock
-1,291$8.00$10k98,156Dec 20, 2024
Dec 19, 2024Azmi Nabulsi
Chief Operating Officer
SOpen-market sale
Common Stock
-1,118$8.00$8,944239,303Dec 20, 2024
Dec 13, 2024Frank Karbe
director
POpen-market purchase
Common Stock
+12,500$7.93$99k57,000Dec 16, 2024
Dec 13, 2024Asit Parikh
director
POpen-market purchase
Common Stock
+10,000$8.12$81k75,500Dec 16, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

PHAT insider trading: Phathom Pharmaceuticals, Inc. | InsiderTell